Central Laboratory Services for Clinical Trial
- Buyer
- BiconY Therapeutics GmbH, Leipzig
- Country
- Germany
- Estimated value
- —
- Deadline
- 4 Nov 2026, 11:00 CET
- Published
- 6 Oct 2026
- Procedure
- Open procedure
- Contract type
- Services
Categories
- 85100000 Health services
From the original notice
The Federal Agency for Disruptive Innovation - SPRIND GmbH ("SPRIND") - aims to create new disruptive innovations from Germany. That means products, services and systems that make all our lives noticeably and sustainably better. To achieve this, SPRIND brings together new thinkers from science and business, people with outstanding ideas, special expertise, and passion. Hence, SPRIND provides an entrepreneurial environment that turns ideas into reality. The objective of BiconY Therapeutics GmbH, a SPRIND subsidiary, is the development of a bispecific antibody combination for the treatment of…
Only the original notice and the buyer's documents are legally binding.